Frequencies for reasonforrecall variable in enfrep20130417 dataset : Reason for Recall | Freq. Percent Cum. ----------------------------------------+----------------------------------- A potential safety risk with the MOS.. | 1 0.89 0.89 Accelerated fatigue of the lateral ax.. | 1 0.89 1.79 Allergenic Extracts, reprocessed by a.. | 1 0.89 2.68 Baseline pulmonary capillary wedge (P.. | 1 0.89 3.57 Blood Bank Software with a defect or .. | 1 0.89 4.46 Blood Bank Software, with a defect or.. | 3 2.68 7.14 Blood product, collected from a donor.. | 1 0.89 8.04 Blood product, collected from a donor.. | 1 0.89 8.93 Blood product, collected that did not.. | 1 0.89 9.82 Blood product, for which storage cond.. | 1 0.89 10.71 Blood product, which was collected fr.. | 1 0.89 11.61 Blood product, which was in transit g.. | 1 0.89 12.50 Blood products, where quality contro.. | 1 0.89 13.39 Blood products, collected from a dono.. | 2 1.79 15.18 Blood products, collected from a dono.. | 1 0.89 16.07 Blood products, collected from a dono.. | 4 3.57 19.64 Blood products, for which shipping an.. | 3 2.68 22.32 Blood products, in which QC was not .. | 5 4.46 26.79 Blood products, prepared without the .. | 1 0.89 27.68 Blood products, which did not meet ac.. | 3 2.68 30.36 Blood products, which did not meet th.. | 1 0.89 31.25 Blood products, which did not meet th.. | 1 0.89 32.14 Blood products, which failed to meet .. | 1 0.89 33.04 Blood products, which may have been e.. | 2 1.79 34.82 Blood products, which were collected .. | 9 8.04 42.86 Blood products, which were collected .. | 1 0.89 43.75 Blood products, which were collected .. | 1 0.89 44.64 Defective Container: This recall is b.. | 1 0.89 45.54 Failed Tablet/Capsule Specifications:.. | 2 1.79 47.32 Firm was made aware of incidents rela.. | 1 0.89 48.21 GE Healthcare has become aware of a p.. | 1 0.89 49.11 GE Healthcare has become aware of an .. | 1 0.89 50.00 GE Healthcare has recently become awa.. | 1 0.89 50.89 Human tissue allograft, recovered fro.. | 1 0.89 51.79 Incubators manufactured prior to mid .. | 1 0.89 52.68 Inspectional observations made during.. | 1 0.89 53.57 It has been found that due to a probl.. | 1 0.89 54.46 It was found that in vHP scan, the es.. | 1 0.89 55.36 It was found that there is a problem .. | 1 0.89 56.25 Kerr Corporation is initiating this r.. | 1 0.89 57.14 LIFEPAK CR Plus or LIFEPAK Express Au.. | 1 0.89 58.04 Labels do not accurately state ingred.. | 1 0.89 58.93 Medtronic is recalling the Medtronic .. | 1 0.89 59.82 Neonatal beds and incubator display b.. | 1 0.89 60.71 One lot of each product may have extr.. | 2 1.79 62.50 Ormco Corporation is voluntarily reca.. | 1 0.89 63.39 Potential to have an internal leak at.. | 2 1.79 65.18 Potentially under processed and repor.. | 1 0.89 66.07 Potentially under processed and repor.. | 1 0.89 66.96 Presence of Foreign Substance: Report.. | 1 0.89 67.86 Product may be contaminated with Salm.. | 1 0.89 68.75 Product may contain wheat allergen. W.. | 1 0.89 69.64 Product samples contain DMAA (Methylh.. | 1 0.89 70.54 Red Eagle Enterprises is recalling Re.. | 3 2.68 73.21 Sesame and Garlic Flavored Mixed Soy .. | 1 0.89 74.11 Siemens has become aware of a potenti.. | 1 0.89 75.00 Siemens has observed that the listed .. | 1 0.89 75.89 Single Use Loading Unit contained two.. | 1 0.89 76.79 Software design error in IMPAX CV 7.8.. | 1 0.89 77.68 Stryker received reports from the fie.. | 1 0.89 78.57 Synthes is initiating a voluntary rec.. | 1 0.89 79.46 The Column rotation can accidentally .. | 1 0.89 80.36 The firm found minute pieces of blue .. | 1 0.89 81.25 The firm received complaints of illne.. | 1 0.89 82.14 The firm voluntarily recalled Biothan.. | 1 0.89 83.04 The firm was notified by their custom.. | 1 0.89 83.93 The mask inside the package has been .. | 1 0.89 84.82 The product contained undeclared sulf.. | 1 0.89 85.71 The product contains an iodine 10% Am.. | 8 7.14 92.86 The product may contain an undeclared.. | 1 0.89 93.75 There is the possibility of what appe.. | 1 0.89 94.64 This recall has been initiated due to.. | 2 1.79 96.43 Unlicenseed blood products were distr.. | 1 0.89 97.32 When using the V5M transducer, the di.. | 1 0.89 98.21 Whole Blood Collection Sets, with a p.. | 1 0.89 99.11 potentially under processed and repor.. | 1 0.89 100.00 ----------------------------------------+----------------------------------- Total | 112 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015